Related Experiment Videos
Genital warts: current and future management options
1Department of Sexual Health, Countess of Chester Hospital NHS Foundation Trust, Chester, England. Colm.OMahony@coch.nhs.uk
American Journal of Clinical Dermatology
|August 3, 2005
Summary
Genital warts, caused by low-risk human papillomavirus, are a cosmetic issue. Home therapies like podophyllotoxin or imiquimod are effective first-line treatments, offering comfort and dignity.
Area of Science:
- Dermatology
- Virology
- Psychology
Background:
- Genital warts are benign lesions caused by specific human papillomavirus (HPV) types.
- While not oncogenic, they cause significant psychological distress and cosmetic concerns.
- Current treatments focus on lesion removal and immune stimulation to prevent recurrence.
Purpose of the Study:
- To review treatment options for genital warts.
- To emphasize the efficacy and patient preference for home-based therapies.
- To highlight the importance of psychological support in managing genital warts.
Main Methods:
- Review of existing literature on genital wart treatments.
- Comparison of physical therapies (cryotherapy, TCA, laser, electrocautery) with home therapies (podophyllotoxin, imiquimod).
- Consideration of patient preference, psychological impact, and recurrence prevention.
Main Results:
- Home therapies, including podophyllotoxin and imiquimod, show excellent patient response rates.
- Patients often prefer home treatment for comfort and privacy.
- Physical treatments are effective but may be less preferred by patients.
Conclusions:
- Home therapies should be considered first-line treatment for most patients with genital warts.
- Addressing the psychological morbidity associated with genital warts is crucial.
- Routine screening for other sexually transmitted infections is recommended.